Interspecies comparison of liver carcinogenesis: Implications for cancer risk assessment

Carcinogenesis

Volumn 18, Issue 1, 1997, Pages 59-81

  Grisham, J W ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL TISSUE; CANCER RISK; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; LIVER CARCINOGENESIS; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT; REVIEW; SPECIES DIFFERENCE;

ANIMALS; CARCINOGENICITY TESTS; DISEASE PROGRESSION; GENE DELETION; GENES, TUMOR SUPPRESSOR; HUMANS; LIVER NEOPLASMS; LIVER NEOPLASMS, EXPERIMENTAL; MICE; PROGNOSIS; RATS; RISK ASSESSMENT; SPECIES SPECIFICITY;

EID: 0031428470     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/18.1.59     Document Type: Review

References (418)

1. Gold, L.S., Slone, T.B., Manley, N.B. and Bernstein, L. (1991) Target organs in chronic bioassays of 533 chemical carcinogens. Environ. Health Perspect, 93, 233-246.
2. Huff J., Cirvello J., Haseman,. and Bucher, J. (1991) Chemicals associated with site-specific neoplasin in 1394 long-term carcinogenesis experiments in laboratory rodents. Environ. Health Perspect., 93, 247-270.
3. Parkin, D.M., Pisani, P. and Ferlay, J. (1993) Estimates of the worldwide incidence of eighteen major cancers in 1985. Int. J. Cancer., 54, 594-606.
4. Frith, C.H. and Ward, J.M. (1980) A morphologic classification of proliferative and neoplastic hepatic lesions in mice. J. Environ. Pathol. Toxicol., 3, 329-351.
5. Institute of Laboratory Animal Resources, National Research Council, National Academy of Sciences. Histologic typing of liver tumors in the rat. J. Natl Cancer Inst., 64, 178-206.
6. Edmundson, H.A. and Steiner, P.E. (1954) Primary carcinoma of the liver. A study of 100 cases among 48,900 necropsies. Cancer, 7, 462-503.
7. Craig, J.R., Peters, R.L. and Edmondson, H.A. (1988) Tumors of the liver and intrahepatic bile Ducts, Armed Forces Institute of Pathology, Washington, DC, pp. 280.
8. Altmann, H.W. (1994) Hepatic neoformations. Pathol. Res. Pract., 190, 513-577.
9. Goldfarb, S. and Pugh, T.D. (1986) Multistage rodent hepatocarcinogenesis, Prog. Liver Dis., 8, 597-620.
10. Danielsen, H.E., Steen, H.B., Lindmo, T. and Reith, A. (1988) Ploidy distribution in experimental liver carcinogenesis in mice. Carcinogenesis, 9, 59-63.
11. Schwarze, P.E., Saeter, G., Armstrong, D., Cameron, R.G., Laconi, E., Sarma, D.S.R., Preat, V. and Seglen, P.O. (1991) Diploid growth pattern of hepatocellular tumors produced by various carcinogenic treatments. Carcinogenesis, 12, 325-327.
12. Anti, M., Marra, G., Rapaccini, G.L. et al. (1994) DNA ploidy pattern in human chronic liver diseases and hepatic nodular lesions: flow cytometric analysis on echo-guided needle liver biopsy. Cancer, 73, 281-288.
13. Cottier, M., Jouffre, C., Maubon, I., Sabido, O., Barthelemy, C., Cuilleron, M., Veyret, C., Laurent, J.-L. and Audigier, J.-C. (1994) Prospective flow cytometric DNA analysis of hepatocellular carcinoma specimens collected by ultrasound fine needle aspirations. Cancer, 74, 599-605.
14. Diwan, B.A., Ward, J.M. and Rice, J.M. (1992) Origin and pathology of hepatoblastoma in mice. In Sirica, A.E. (ed.), The role of cell types in hepatocarcinogenesis, CRC Press, Boca Raton, pp. 71-87.
15. Howell, S., Wareham, K.A. and Williams, E.D. (1985) Clonal origin of mouse liver tumors. Am. J. Pathol., 121, 426-432.
16. Lee, G.-H., Nomura, K., Kanda, H., Kusakabe, M., Yoshiki, A., Sakakura, T. and Kitigawa, T. (1991) Strain specific sensitivity to diethylnitrosamineinciuced carcinogenesis is maintained in hepatocytes of C3H/ HeN[↔]C57BL/6N chimeric mice. Cancer Res., 51, 3257-3260.
17. Tsunashima, K., Endo, Y., Asakura, H., Kanda, H., Nomura, K., Kitagawa, T. and Kominami, R. (1996) A novel clonality assay for the mouse: application to hepatocellular carcinoma induced with diethylnitrosamine. Mol. Carcinogenesis, 15, 33-37.
18. Shafritz, D.A., Shouval, D., Sherman, H.I., Hadziyannis, S.J. and Kew, M.C. (1981) Integration of hepatitis B virus DNA into the genome of liver cells in chronic liver disease and hepatocellular carcinoma. Studies on percutaneous liver biopsies and post-mortem specimens. N. Engl. J. Med., 305, 1067-1073.
19. Esumi, M., Aritaka, T., Arii, M., Suzuki, K., Tanikawa, K., Mizuo, H., Mima, T. and Shikata, T. (1986) Clonal origin of human hepatoma determined by integration of hepatitis B virus DNA. Cancer Res., 46, 5767-5771.
20. Tsuda, H., Hirohashi, S., Shimosato, Y., Terada, M. and Hasegawa, H. (1988) Clonal origin of atypical adenomatous hyperplasia of the liver and clonal identity with hepatocellular carcinoma. Gastroenterol, 95, 1664-1666.
21. Aoki, N. and Robinson, W.N. (1989) State of the hepatitis B viral genomes in cirrhosis and hepatocellular carcinoma nodules. Mol. Biol. Med., 6, 395-408.
22. Kawai, S., Imazeki, F., Yokosuka, O., Ohto, M., Shima, S., Kato, N. and Omata, M. (1995) Clonalily in hepatocellular carcinoma: analysis of methylation pattern of pleomorphic X-chromosome-linked phosphoglycerate kinase gene in females. Hepatol., 22, 112-117.
23. Gaffey, M.J., Iezzoni, J.C and Weiss, L.M. (1996) Clonal analysis of focal nodular hyperplasia of the liver. Am. J. Pathol., 148, 1089-1096.
24. Iannaccone, P.M. (1987) The study of mammalian organogenesis by mosaic pattern analysis. Cell Differ., 21, 79-91.
25. Bannasch, P. and Zerban, H. (1990) Tumors of the liver. In Turusov, V.S. and Mohr, U. (eds). Pathology of tumors in laboratory animals, 2nd Edn, Vol. 1, Tumors in the rat, IARC Scientific Publishers, Lyon, France, pp. 199-240.
26. Turusov, V.S. and Takayama, S. (1979) Tumors of the liver. In Turusov, V.S. (ed.), Pathology of tumors of the laboratory mouse, Vol II., IARC Scientific Publishers, Lyon, France, pp. 193-233.
27. Bannasch, P. and Zerban, H. (1992) Predictive value of hepatic preneoplastic lesions as indicators of carcinogenic response. In Vainio, H., Magee, P.N., McGregor, D.B. and McMichael, A.J. (eds). Mechanisms of carcinogenesis in risk identification, IARC Scientific Publishers, Lyon, France, pp. 389-427.
28. Kaufmann, W.K., Zhang, Y. and Kaufman, D.G. (1992) Association between transforming growth factor-alpha and conversion of hepatocellular foci to neoplasms. Carcinogenesis, 13, 1481-1483.
29. Tanno, S. and Ogawa, K. (1994) Abundant TGFα precursor and EGF receptor expression as a possible mechanism for the preferential growth of carcinogen-induced preneoplastic and neoplastic hepatocytes in rats. Carcinogenesis, 15, 1689-1694.
30. Norstedt, G., Levinovitz, A., Möller, C., Eriksson, L.C. and Andersson, G. (1988) Expression of insulin-like growth factor I(IGF-I) and IGF-II mRNA during hepatic development, proliferation and carcinogenesis in the rat. Carcinogenesis, 9, 209-213.
31. Cariani, E., Dubois, N., Lasserre, C., Briand, P. and Brechot, C. (1991) Insulin-like growth factor II (IGF-II) mRNA expression during hepatocarcinogenesis in transgenic mice. J. Hepatol., 13, 220-226.
32. Yang, D. and Rogler, C.E. (1991) Analysis of insulin-like growth factor II (IGF-II) expression in neoplastic nodules and hepatocellular carcinomas of woodchucks utilizing in situ hybridization and immunohistochemistry. Carcinogenesis, 12, 1893-1901.
33. Maronpot, R.R., Montgomery, CA., Boorman, G.A. and McConnell, E.E. (1986) National Toxicology Program nomenclature for hepatoproliferative lesions of rats. Toxicol. Pathol., 14, 263-273.
34. Rabes, H.N., Bucher, T., Hartman, A., Linke, I. and Dunnwald, M. (1982) Clonal origin of carcinogen-induced enzyme-deficient preneoplastic populations in the mouse. Cancer Res., 42, 3220-3227.
35. Weinberg, W.C., Berkwits, L. and Jannaccone, P.M. (1987) The clonal nature of carcinogen-induced altered foci of γ-glutamyl transpeptidase expression in rat liver. Carcinogenesis, 8, 565-570.
36. Tsuji, S., Ogawa, K., Takasaka, H., Sonoda, T. and Mori, M. (1988) Clonal origin of γ-glutamyl transpeptidase-positive hepatic lesions induced by initiation-promotion in ornithine carbamoyltransferase mosaic mice. Japan. J. Cancer Res., 79, 148-151.
37. Weinberg, W.C. and Iannaccone, P.M. (1988) Clonality of preneoplastic liver lesions: histological analysis in chimeric rats. J. Cell Sci., 89, 423-431.
38. Popper, H., Thung, S.N., McMahon, B.J., Lanier, A.P., Hawkins, I. and Alberts, S.B. (1988) Evolution of hepatocellular carcinoma associated with chronic hepatitis B virus infection in Alaskan Eskimos. Arch. Pathol. Lab. Med., 112, 498-504.
39. Unoura, M., Kaneko, S., Matsushita, E. et al. (1993) High-risk groups and screening strategies for early detection of hepatocellular carcinoma in patients with chronic liver disease, Hepato-gasiroenterol., 40, 305-310.
40. Johnson, P.J. and Williams, R. (1987) Cirrhosis and the etiology of hepatocellular carcinoma. J. Hepatol., 4, 140-147.
41. Anthony, P.P., Ishak, K.G., Nayak, N.C., Paulsen, H.E., Scheuer, P.J. and Sobin, L.H. (1978) The morphology of cirrhosis. Recommendations on definition, nomenclature, and classification by a working group sponsored by the World Health Organization. J. Clin. Pathol., 31, 395-414.
42. Watanabe, S., Okita, K., Harada, T., Kodama, T., Numa,Y., Takemoto, T. and Takahashi, T. (1982) Morphologic studies of the liver dysplasia. Cancer, 51, 2197-2205.
43. Thomas, R.M., Berman, J.J., Yetter, R.A., Moore, G.W. and Hutchins, G.M. (1992) Liver cell dysplasia: a DNA aneuploid lesion with distinct morphologic features. Human Pathol., 23, 496-503.
44. Yasui, H., Hino, O., Ohtake, K., Machinami, R. and Kitagawa, T. (1992) Clonal growth of hepatitis B virus-integrated hepatocytes in cirrhotic liver nodules. Cancer Res., 52, 6810-6814.
45. Aihara, T, Noguchi, S., Sasaki, Y., Nakano, H. and Imaoka, S. (1994) Clonal analysis of regenerative nodules in hepatitis C virus-induced liver cirrhosis. Gastroenterology, 107, 1805-1811.
46. Lanier, A.P., McMahon, B.J., Alberts, S.R., Popper, H. and Heyward, W.L. (1987) Primary liver cancer in Alaskan natives 1980-1985. Cancer, 60, 1915-1920.
47. NaKanuma, Y., Terada, T., Ueda, K., Terasaki, S., Nonomura, A. and Matsui, O. (1993) Adenomatous hyperplasia of the liver as a precancerous lesion. Liver, 13, 1-9.
48. Ferrell, L.D., Crawford, J.M., Dhillon, A.P., Schever, P.J. and Nakanuma, Y (1993) Proposal for standardized criteria for the diagnosis of benign, borderline, and malignant hepatocellular lesions arising in chronic advanced liver disease. Am. J. Surg. Pathol., 17, 1113-1123.
49. International Working Party (1995) Terminology of nodular hepatocellular lesions. Hepatology, 22, 983-993.
50. Borzio, M., Bruno, S., Roncalli, M., Mels, G.C., Ramella, G., Borzio, F., Leandro, G., Servida, E. and Podda, M. (1995) Liver cell dysplasia is a major risk factor for hepatocellular carcinoma in cirrhosis: a prospective study. Gastroenterology, 108, 812-817.
51. Stromeyer, F.W. and Ishak, K.G. (1981) Nodular transformation (nodular 'regenerative' hyperplasia) of the liver. A clinicopathologic study of 30 cases. Human Pathol., 12, 60-71.
52. Bannasch, P. and Klinge, O. (1971) Hepatocelluläre glykogenose und hepatombildung beim menschen. Virchows Arch. A, 352, 157-164.
53. Cain, H. and Kraus, B. (1977) Entwicklungsstörungen der leber und leberkarzinom im sauglings-und kindesalter. Dtsch. Med. Wschr., 102, 505-509.
54. Fischer, G., Hartmann, H., Droese, M., Schaver, A. and Bock, K.W. (1986) Histochemical and immunohistochemical detection of putative preneoplastic foci in women after long-term use of oral contraceptives. Virchows Arch. B, 50, 321-337.
55. Uchida, T., Miyata, H. and Shikata, T. (1981) Human hepatocellular carcinoma and putative precancerous disorders. Arch. Pathol. Lab. Med., 105, 180-186.
56. Thung, S.N. and Gerber, M. A. (1981) Enzyme patterns and marker antigens in nodular 'regenerative' hyperplasia of the liver. Cancer, 47, 1796-1799.
57. Hirota, N., Hamazaki, M. and Williams, G.M. (1982) Resistance to iron accumulation and presence of hepatitis B surface antigen in preneoplastic and neoplastic lesions in human hemochromatotic livers. Hepatogastroenterol., 29, 49-51.
58. Karhunen, DJ. and Penttilä, A. (1987) Preneoplastic lesions of human liver. Hepato-gastroenterol., 34, 10-15.
59. Bannasch, P., Jahn, U.-R. and Zerban, H. (1992) Preneoplastic lesions as early indicators of neoplastic development. In Bannasch,P. (ed.), Cancer diagnosis. Early detection. Springer-Verlag, Berlin, pp. 178-190.
60. Terada, T. and Nakanuma, Y (1989) Iron-negative foci in siderotic macroregenerative nodules in human cirrhotic liver. A marker of incipient neoplastic lesions. Arch. Pathol. Lab. Med., 113, 916-920.
61. Terada, T. and Nakanuma, Y. (1989) Survey of iron-accumulative macroregenerative nodules in cirrhotic livers. Hepatol., 10, 851-854.
62. Govindarajan, S., Conrad, A., Lim, B., Valinluck, B., Kim, A.M. and Schmid, P. (1990) Study of preneoplastic changes in liver cells by immunohistochemical and molecular hybridization techniques. Arch. Pathol. Lab. Med., 114, 1042-1045.
63. Bannasch, P., Jahn, U.-R., Hoffmann, W., Pichlmayr, R. and Otto, G. (1996) Focal hepatic glycogenosis: a putative preneoplastic lesion associated with neoplasia and cirrhosis in explanted livers, submitted.
64. Deugnier, Y.M., Charalambous, P., LeQuilleuc, D., Turlin, B., Searle, J., Brissot, P., Powell, L.W. and Halliday, J.W. (1993) Preneoplastic significance of hepatic iron-free foci in genetic hemochromatosis: a study of 185 patients. Hepatology, 18, 1363-1369.
65. Degunier, Y.M., Guyader, D., Crantock, L. et al. (1993) Primary liver cancer in genetic hematochromatosis: A clinical, pathological, and pathogenetic study of 54 cases. Gastroenterology, 104, 228-234.
66. Terada, T., Kadoya, M., Nakamura, Y. and Matsui, O. (1990) Ironaccumulating adenomatous hyperplastic nodule with malignant focui in the cirrhotic liver. Histologie, quantitative iron, and magnetic resonance imaging in vitro studies. Cancer, 65, 1994-2000.
67. Popper, H., Shih, J.W.-K., Gerin, J.L., Wong, D.C., Hoyer, B.H., London, W.T., Sly, D.L. and Purcell, R.H. (1981) Woodchuck hepatitis and hepatocellular carcinoma: correlation of histologie with virologic findings, Hepatology, 1, 91-98.
68. Marion, P.L., VanDavelaar, M.J., Knight, S.S., Salazar, F.H., Garcia, G., Popper, H. and Robinson, W.S. (1986) Hepatocellular carcinoma in ground squirrels persistently infected with ground squirrel hepatitis virus. Proc. Natl Acad. Sci., 83, 4543-4546.
69. Toshkov, I., Hacker, H.J., Roggendorf, M. and Bannasch, P. (1990) Phenotypic patterns of preneoplastic and neoplastic hepatic lesions in woodchucks infected with woodchuck hepatitis virus. J. Cancer Res. Clin. Oncol., 116, 581-590.
70. Toshkov, I., Chisari, F.V. and Bannasch, P. (1994) Hepatic preneoplasia in hepatitis B virus transgenic mice. Hepatology, 20, 1162-1172.
71. Office of Science and Technology Policy (1984) Chemical carcinogens; notice of review of the science and its associated principles. Federal Reg., 49, 21594-21661.
72. Sheridan, M.J. (1992) Analytical epidemiology: techniques to determine causal relationships, In Higginson, J., Muir, C.S. and Munoz, N. (eds), Human cancer: Epidemiology and environmental causes. Cambridge University Press, Cambridge, pp. 27-37.
73. International Agency for Research on Cancer (1994) IARC Monographs on the evaluation of Carcinogenic risks to humans, Vol. 59, Hepatitis viruses, IARC Scientific Publications, Lyon, France, p. 286.
74. International Agency for Research on Cancer. (1994) IARC Monographs on the evaluation of carcinogenic risk to humans, Vol. 56, Some naturally occurring substances: Food items and constituents, heterocyclic aromatic amines and mycotoxins, IARC Scientific Publications, Lyon, France (see section on aflatoxins), pp. 245-395.
75. Peers, F., Bosch, X., Kaldor, J., Linsell, A. and Pluijmen, M. (1987) Aflatoxin exposure, hepatitis B virus infection and liver cancer in Swaziland. int. J. Cancer, 39, 545-553.
76. Ross, R.K., Yuan, J.-N., Yu, M.C., Wogan, G.N., Qian, G.-S., Tu, J.-T., Groopman, J.O., Gao, Y.-T. and Henderson, B.E. (1992) Urinary aflatoxin biomarkers and risk of hepatocellular cancer. Lancet, 339, 943-946.
77. Qian, G.-S., Ross, R., Yu, M.C., Yuan, J.-M., Gao, Y.-T., Henderson, B.E., Wogan, G.N. and Groopman, J.D. (1994) A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China. Cancer Epidemiol. Biomark. Prev., 3, 3-10.
78. Vainio, H. and Wilbourn, J. (1993) Cancer etiology: agents associated with human cancer. Pharmac. Toxicol., 72, S4-S11.
79. International Agency for Research on Cancer (1996) IARC Monographs on the evaluation of Carcinogenic risk to humans, Vol. 66, Some medicinal drugs, IARC Scientific Publications, Lyon, France, in press.
80. International Agency for Research on Cancer (1988) IARC Monographs on the evaluation of Carcinogenic risks to humans. Vol. 44, Alcohol drinking, IARC Scientific Publications, Lyon, France, pp. 207-215.
81. Chen, C.-J., Chen, C.W., Wu, M.-M. and Kuo, T.-L. (1992) Cancer potential in liver, lung, bladder and kidney due to ingested inorganic arsenic in drinking water. Brit. J. Cancer, 66, 888-892.
82. Andersson, M. and Storm, H.H. (1992) Cancer incidence among Danish Thoratrast-exposed patients. J. Natl Cancer Inst., 84, 1318-1325.
83. Andersson, M., Vyberg, M., Visfeldt, J., Carstensen, B. and Storm, H.H. (1994) Primary liver tumors among Danish patients exposed to Thoratrast. Radiat. Res., 137, 262-273.
84. Trichopoulos, D., MacMahon, B., Sparros, L. and Merikas, G. (1980) Smoking and hepatitis B-negative primary hepatocellular carcinomas. J. Natl Cancer Inst., 65, 111-114.
85. Hirayama, T. (1989) A large-scale cohort on risk factors for primary fiver cancer, with special reference to the role of cigarette smoking. Cancer Chemother. Pharmacol., 23(Suppl.), S114-S117.
86. Chen, C-J., Liang, K.-Y., Chang, A.-S., Chang, Y.-C., Lu, S.-N., Liaw, Y.-F., Chang, W.-Y., Sheen, M.-C. and Lin, T.-M. (1991) Effects of hepatitis B virus, alcohol drinking, cigarette smoking, and familial tendency on hepatocellular carcinoma. Hepatol., 13, 398-406.
87. Yu, M.C., Tong, M.J., Govindjaran, S. and Henderson, B.E. (1991) Nonviral risk factors for hepatocellular carcinoma in a low-risk population, the non-Asians of Los Angeles County, California. J. Natl Cancer Inst. 83, 1820-1826.
88. Yu, M.C., Chen, C.-J., Luo, J.-C, Brandt-Rauf, P.W., Carney, W.P. and Santella, R.M (1994) Correlations of chronic hepatitis B virus and cigarette smoking with elevated expression of neu oncoprotein in the development of hepatocellular carcinoma. Cancer Res., 54, 5106-5110.
89. Austin, H., Delzell, E., Grufferman, S., Levine, R., Morrison, A.S., Stolley, P.D. and Cole, P. (1982) A case-control study of hepatocellular carcinoma and the hepatitis B virus, cigarette smoking, and alcohol consumption. Cancer Res, 46, 962-966.
90. Tsukuma, H., Hiyama, T., Oshima, A. et al. (1990) A case-control study of hepatocellular carcinoma in Osaka, Japan. Int. J. Cancer, 45, 231-236.
91. Tanaka, T., Hirohata, T., Takeshita, S., Hirohata, I., Koga, S., Sugimachi, K., Kanematsu, T., Ohryohji, F. and Ishibashi, H. (1992) Hepatitis B virus, cigarette smoking and alcohol consumption in the development of hepatocellular carcinoma: a case-control study in Fukuoka, Japan. Int. J. Cancer, 51, 509-514.
92. Stemhagen, A., Slade, J., Altman, R. and Bill, J. (1983) Occupational risk factors and liver cancer. A retrospective case-control study of primary liver cancer in New Jersey. Am. J. Epidemiol., 117, 443-454.
93. Hardell, L., Bengtsson, N.O., Jonsson, U., Enksson, S. and Larsson, L.G. (1984) Etiological aspects on primary liver cancer with special regard to alcohol, organic solvents and acute intermittent porphyria - an epidemiological investigation. Brit. J. Cancer, 50, 389-397.
94. Austin, H., Delzell, E., Grufferman, S., Levine, R., Morrison, A.S., Stolley, P.D. and Cole, P. (1987) Case-control study of hepatocellular carcinoma, occupation, and chemical exposure. J. Occup. Med., 29, 665-669.
95. Bulkley, J.D., Sather, H., Ruccione, K., Rogers, P.C.J., Haas, J.E., Henderson, B.E. and Hammond, G.D. (1989) A case-control study of risk factors for hepatoblastoma. A report from the Children's Cancer Study Group. Cancer, 64, 1169-1176.
96. Cordier, S., Thuy, L.T.B., Verger, P., Bard, D., Dai, L.L., Larouze, B., Dazza, M., Quinh, H.T. and Abenham, L. (1993) Viral infections and chemical exposures as risk factors for hepatocellular carcinoma in Vietnam. Int. J. Cancer, 55, 196-201.
97. The Selected Cancers Cooperative Study (1990) The association of selected cancers with service in the US military in Vietnam III. Hodgkin's disease, nasal cancer, nasopharyngeal cancer, and primary liver cancer. Arch. Intern. Med., 150, 2495-2505.
98. Niederau, C., Fischer, R., Sonnenberg, A., Stremmel, W., Trampisch, H.J. and Strohmeyer, G. (1985) Survival and causes of death in cirrhotic and noncirrhotic patients with primary hemochromatosis. N. Engl, J. Med., 313, 1256-1262.
99. Bianchi, L. (1993) Glycogen storage disease J and hepatocellular tumors. Eur. J. Pediatr., 152(Suppl. 1), 563-570.
100. Wilkinson, M.L., Portmann, B. and Williams, R. (1983) Wilson's disease and hepatocellular copper: possible protective role of copper. Cut, 24, 767-771.
101. 1-antitrypsin deficiency. N. Engl. J. Med., 314, 736-739.
102. Russo, P. and O'Reagan, S. (1990) Visceral pathology of hereditary tyrosinemia type 1. Am. J. Hum. Genet. 47, 317-324.
103. Weinstein, S., Scottalini, A.G., Loo, S.Y.T., Caldwell, P.C. and Bhagavan, N.V. (1985) Ataxia telangiectasia with hepatocellular carcinoma in a 15-year-old girl and studies of her kindred. Arch. Pathol. Lab. Med., 109, 1000-1004.
104. Jameson, C.F. (1989) Primary hepatocellular carcinoma in hereditary hemorrhagic telangiectasia. Histopathol., 15, 550-552.
105. Lithner, F. and Wetterberg, L. (1984) Hepatocellular carcinoma in patients with acute intermittent porphyria. Acta Med. Scand., 215, 271-274.
106. Kauppinen, R. and Mustajoki, P. (1988) Acute hepatic porphyria and hepatocellular cancer. Brit. J. Cancer, 57, 117-120.
107. Siersma, P.D., tenKate, F.J.W., Mulder, P.G.H. and Wilson, J.H.P. (1992) Hepatocellular carcinoma in porphyria cutanea tarda, frequency and factors in its occurrence. Liver, 12, 58-61.
108. Coleman, W.B. and Tsongalis, G.J. (1995) Multiple mechanisms account for genomic instability and molecular mutation in neoplastic transformation. Clin. Chem., 41, 644-657.
109. 1 carcinogenicity, Proc. Soc. Exp. Biol Med., 208, 213-227.
110. Yu, M.-W., Gladek-Yarborough, A., Chiamprasert, S., Santella, R.M., Liaw, Y-K and Chen, C.-J- (1995) Cytochrome P450 2E1 and glutathione S-transferase Ml polymorphisms and susceptibility to hepatocellular carcinoma. Gastroenterology, 109, 1266-1273.
111. Wild, C.P., Hasegawa, R., Berraud, L., Chutimatdewin, S., Chapot, B., Ito, N. and Montesano, R. (1996) Aflatoxin-albumin adducts, a basis for competitive carcinogenesis between animals and humans. Cancer Epid. Biomark, Prev., 5, 179-189.
112. 1. Proc. Natl Acad. Sci. USA, 92, 2384-2387.
113. Alberts, S.R., Lanier, A.P., McMahon, B.J., Harpster, A., Bulkow, L.R., Heyward, W.L. and Murray, C. (1991) Clustering of hepatocellular carcinoma in Alaska native families. Genet. Epidemiol., 8, 127-139.
114. Shen, E-M., Lee, M.K., Gong, H.-M., Cai, X.-Q. and King, M.C. (1991) Complex segregation analysis of hepatocellular carcinoma in Chinese families, interaction of inherited susceptibility and hepatitis B viral infection. Am. J. Hum. Genet., 49, 88-93.
115. Harris, C.C. and Sun, T.-T. (1984) Multifactoral etiology of human liver cancer. Carcinogenesis, 5, 697-701.
116. Stroffolini, T., Chiaramonte, M., Tiribelli, C. et al (1992) Hepatitis C virus infection, HBsAg carrier state and hepatocellular carcinoma, relative risk and population attributable risk from a case-control study in Italy. J. Hepatol., 16, 360-363.
117. Benvegnù, L., Fattovich, G., Noventa, F., Tremolada, F., Chemello, L., Cecchetto, A. and Alberti, A. (1994) Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis. Cancer, 74, 2442-2448.
118. Nalpas, B., Feitelson, M., Brechot, C., and Rubin, E. (1995) Alcohol, hepatotropic viruses and hepatocellular carcinoma. Alcoholism Clin. Exp. Res., 19, 1089-1095.
119. Noda, K., Yoshihara, H., Suzuki, K., Yamada, Y., Kasahara, A., Hayashi, N., Fusamoto, H. and Kamada, T. (1996) Progression of type C chronic hepatitis to liver cirrhosis and hepatocellular carcinoma-its relationship to alcohol drinking and age of transfusion. Alcohol. Clin. Exp. Res., 20, 95A-100A.
120. Ikeda, K., Saitoh, S., Koida, I., Arase, Y., Tsubota, A., Chayama, K., Kumada, H. and Kawanishi, J. (1993) A multivariate analysis of risk factors for hepatocellular carcinogenesis, a prospective observation of 795 patients with viral and alcoholic cirrhosis. Hepatology, 18, 47-53.
121. Tanaka, K., Hirohata, T., Koga, S. et al. (1991) Hepatitis C and B in the etiology of hepatocellular carcinoma in the Japanese population. Cancer Res., 51, 2842-2847.
122. Rocchi, E., Gibertini, P., Caranelli, M., Pietrangelo, A., Jenson, J. and Venmra, E. (1986) Hepatitis B virus infection in porphyria cutanea tarda. Liver, 6, 153-157.
123. Gold, L.S., Manley, N.B., Slone, T.H., Garfinkel, G.B., Ames, B.N., Rohrbach, L., Stern, B.R. and Chow, K. (1995) Sixth plot of the Carcinogenic Potency Database, results of animal bioassays published in the general literature 1989 to 1990 and by the National Toxicology Program 1990 to 1993. Environ. Health Perspect., 103(Suppl. 8), 3-123.
124. Gold, L.S., Slone, T.H., Stern, B.B. and Bernstein, L. (1993) Comparison of target organs of carcinogenicity for mutagenic and non-mutagenic chemicals. Mutat. Res., 186, 75-100.
125. Ward, J.M., Fox, J.G., Anver, M.R. et al. (1994) Chronic active hepatitis and associated liver tumors in mice caused by a persistent bacterial infection with a novel Helicobacter species. J. Natl Cancer Inst., 86, 1222-1227.
126. International Agency for Research on Cancer (1994) IARC Monographs on the evaluation of carcinogenic risks to humans, Vol. 61, Schistosomes, liver flukes and Helicobacter pylori. IARC Scientific Publications, Lyon, France, pp. 127-240.
127. Sakamoto, H., Sawada, N., Kamimura, Y., Enomoto, K. and Mori, M. (1993) High sensitivity of LEC rats with chronic hepatitis to hepatocarcinogenesis, decreases in unscheduled and replicative DNA synthesis of the hepatocytes. Japan. J. Cancer Res., 84, 966-971.
128. Muramatsu, Y., Yamada, T., Miura, M., Sakai, T., Suzuki, Y., Serikawa, T., Tanzi, R. and Matsumoto, K. (1994) Wilson's disease gene is homologous to hts causing abnormal copper transport in Long-Evans Cinnamon rats. Gastroenterology, 107, 1189-1192.
129. Cox, D.W. (1985) Genes of the copper pathway. Am. J. Hum. Genet., 56, 828-830.
130. Grompe, M., Lindstedt, S., Al-Dhalimy, M., Kenneway, N.G., Papaconstantinou, J., Torres-Ramos, C.A., Ou, C.-N. and Finegold, M. (1995) Pharmacological correction of neonatal lethal hepatic dysfunction in a murine model of tyrosinemia type 1. Nature Genet., 10, 453-460.
131. Sher, S.P., Jensen, R.D. and Bokelman, D.L. (1982) Spontaneous tumors in control F344 and Charles River-CD rats and Charles River CD-1 and B6C3HF1 mice. Toxicol. Lett., 11, 103-110.
132. Rao, G.N., Birnbaum, L.S., Collins, J.J., Tennant, R.W. and Skow, L.L. (1988) Mouse strains for chemical carcinogenicity studies, overview of a workshop. Fund. Appl. Toxicol., 10, 385-394.
133. Dragani, T.A., Maneti, G., Gariboldi, M., Falvella, F.S., Pierotti, M.A. and DellaPorta, G. (1992) Genetics of hepatocarcinogenesis in mouse and man. In Zervos, C. (ed.), Oncogene and transgenics correlates of cancer risk assessments. Plenum Press. New York, pp. 67-80.
134. Drinkwater, N.R., Hanigan, M.H. and Kemp, C.J. (1989) Genetic determinants of hepatocarcinogenesis in the B6C3F1 mouse. Toxicol. Lett., 49, 255-265.
135. Gariboldi, M., Manenti, G., Canzian, F., Falvella, F.S., Pierotti, M.A., DellaPorta, G., Sinelli, G. and Dragani, T.A. (1993) Chromosome mapping of murine liver tumor loci to liver carcinogenesis. Cancer Res., 53, 209-211.
136. Manenti, G., Binelli, G., Gariboldi, M., Canzian, F., DeGregorio, L., Falvella, F.S., Dragani, T.A. and Pierotti, M.A. (1994) Multiple loci affect genetic predisposition to hepatocarcinogenesis in mice. Genomics, 23, 118-124.
137. Lee, G.-H. and Drinkwater, N.R. (1995) The Her (hepatocarcinogen resistance) loci of DBA/2J mice partially suppress phenotypic expression of HCS (hepatocarcinogen sensitivity) loci of C3H/HeJ mice. Carcinogenesis, 16, 1993-1996.
138. Purchase, I.F.H. (1980) Inter-species comparisons of carcinogenicity. Brit. J. Cancer, 41, 454-468.
139. Ashby, J. and Tennant, R.W. (1988) Chemical structure, Salmonella mutagenicity and extent of carcinogenicity as indicators of genotoxic carcinogenesis among 222 chemicals tested in rodents by the US NCI/ NTP. Mutat. Res., 204, 17-115.
140. Gold, L.S., Manley, N.B. and Ames, B.N. (1992) Extrapolation of carcinogenicity between species, qualitative and quantitative factors. Risk Anal., 12, 579-588.
141. Vancutsem, P.M., Lazarus, P. and Williams, G.M. (1994) Frequent and specific mutations of the rat p53 gene in hepatocarcinomas induced by tamoxifen. Cancer Res., 54, 3864-3867.
142. Ennever, F.K., Noonan, T.J. and Rosenkranz, H.S. (1987) The predictivity of animal bioassays and short-term genotoxicity tests for carcinogenicity and non-carcinogenicity in humans. Mutagenesis, 2, 73-78.
143. Marselos, M. and Vainio, H. (1991) Carcinogenic properties of pharmaceutical agents evaluated in the IARC Monographs programme. Carcinogenesis, 12, 1751-1766.
144. Yager, J.D., Zurlo, J. and Ni, N. (1991) Sex hormone and tumor promotion in the liver. Proc. Soc. Exp. Biol. Med., 198, 667-674.
145. Schulte-Hermann, R. (1985) Tumor promotion in the liver. Arch. Toxicol., 57, 147-158.
146. Peraino, C. (1981) Initiation and promotion of (iver tumorigenesis. Natl Cancer Inst. Monogr., 58, 55-61.
147. White, S.J., McLean, A.E.M. and Howland, C. (1979) Anticonvulsant drugs and cancer, a cohort study in patients with severe epiJepsy. Lancet, 2, 458-461.
148. Shirts, S.B., Annegers, J.F., Hauser, W.A. and Kurland, L.T. (1986) Cancer incidence in a cohort of patients with seizure disorders. J. Natl Cancer Inst., 77, 83-87.
149. Olsen, J.H., Boice, J.D., Jensen, J.P. and Fraumeni, J.F. (1989) Cancer among epileptic patients exposed to amiconvulsam drugs. J. Natl Cancer Inst., 81, 803-808.
150. Porta, E.A., Markell, N. and Dorado, R.D. (1985) Chronic alcoholism enhances hepatocarcinogenecity of diethylnitrosamine in rats fed a marginally methyl-deficient diet. Hepatology, 5, 1120-1125.
151. Takada, A., Nei, J. Takase, S. and Matsuda, Y. (1986) Effects of ethanol on experimental hepatocarcinogenesis. Hepatology, 6, 65-72.
152. Yamagiwa, K., Mizumoto, R., Higashi, S., Kato, H., Tomida, T., Uehara, S.-I., Tanigawa, K., Tanaka, M. and Ishida, N. (1994) Alcohol ingestion enhances hepatocarcinogenesis induced by synthetic estrogen and progestin in the rat. Cancer Detect, Prev., 18, 103-114.
153. Froment, O., Boivin, S., Barbin, A., Bancel, B., Trepo, C. and Marion, M.-J. (1994) Mutagenesis of ras proto-oncogenes in rat liver tumors induced by vinyl chloride. Cancer Res., 54, 5340-5345.
154. Marion, M.J., Froment, O. and Trepo, C. (1991) Activation of Ki-ras gene by point mutation in human liver angiosarcoma associated with vinyl chloride exposure. Mol. Carcinogenesis, 4, 450-454.
155. Zerban, H., Radig, S., Kopp-Schneider, A. and Bannasch, P. (1994) Cell proliferation and cell death (apoptosis) in hepatic preneoplasia and neoplasia are closely related to phenotypic cellular diversity and instability. Carcinogenesis, 15, 2467-2473.
156. Farber, E. and Sarma, D.S.R. (1987) Hepatocarcinogenesis, a dynamic cellular perspective. Lab. Invest., 56, 4-22.
157. Schulte-Hermann, R., Bursh, W. and Grasl-Kraupp, B. (1995) Active cell death (apoptosis) in liver biology and disease. Prog. Liver Dis., 13, 1-35.
158. Sell, S. and Dunsford, H.A. (1989) Evidence for the stem cell origin of hepatocellular carcinoma and cholangiocarcinoma. Am. J. Pathol., 134, 1347-1361.
159. Fu, X., Su, X., Lee, C.Y., Hintz, R., Biempica, L., Snyder, R. and Rogler, C.E. (1988) Insulin-like growth factor II expression and oval cell proliferation associated with hepatocellular carcinogenesis in woodchuck hepatitis virus carriers. J. Virol., 62, 3422-3438.
160. Tsao, M.-S. and Grisham, J.W. (1987) Hepatocarcinomas, cholangiocarcinomas and hepatoblastomas produced by chemically transformed cultured rat liver epithelial cells. A light and electron microscopic study. Am. J. Pathol., 127, 168-181.
161. Hsia, C.C., Evarts, R.P., Nakatsukasa, H., Marsden, E.R. and Thorgeirsson, S.S. (1992) Occurrence of oval-type cells in hepatitis B virus-associated human hepatocarcinogenesis. Hepatology, 16, 1327-1333.
162. Hsia, CC, Thorgeirsson, S.S. and Tabor, E. (1994) Expression of hepatitis B surface and core antigens and transforming growth factor-cc in 'oval cells' of the liver in patients with hepatocellular carcinoma. J. Med. Virol., 43, 216-221.
163. Hoel, D.G., Haseman, J.R., Hogan, M.D., Huff, J. and McConnell, E.E. (1988) The impact of toxicity on carcinogenicity studies, implications for risk assessment. Carcinogenesis, 9, 2045-2052.
164. Tennant, R.W., Elwell, M.R., Spalding, J.W. and Griesemer, R.A. (1991) Evidence that toxic injury is not always associated with induction of chemical carcinogenesis. Mol. Carcinogenesis., 4, 420-440.
165. Hartwell, L.H. and Kastan, M.B. (1994) Cell cycle control and cancer. Science, 266, 1821-1828.
166. Fausto, N. (1991) Growth factors in liver development, regeneration and carcinogenesis. Prog. Growth Factor Res., 3, 219-234.
167. Miller, R.T., Cattley, R.C., Marsman, D.S., Lyght, O. and Popp, J.A. (1995) TGFα is differentially expressed in liver foci induced by diethylnitrosamine initiation and peroxisome proliferator promotion. Carcinogenesis, 16, 77-82.
168. Dragan, Y., Teeguarden, J., Campbell, H., Hsia, S. and Pitot, H. (1995) The quantitation of altered hepatic foci during multistage hepatocarcinogenesis in the rat, transforming growth factor a expression as a marker of the stage of progression. Cancer Lett., 93, 73-83.
169. Jirtte, R.L. and Meyer, S.A. (1991) Liver tumor promotion, effect of phenobarbital on EGF and protein kinase C signal transduction and transforming growth factor -βl expression. Digest. Dis. Sci., 36, 659-688.
170. Jhappan, C., Siahle, C., Harkms, R.N., Fausto, N., Smith, G.H. and Merlino, G.T. (1990). TGFα overexpression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreas. Cell, 61, 1137-1146.
171. Russell, W.E., Kauf mann, W.K., Sitaric, S., Luetteke, N.C. and Lee, D.C. (1996) Liver regeneration and hepatocarcinogenesis in transforming growth
172. Castilla, A., Prieto, J. and Fausto, N. (1991) Transforming growth factor βl and α in chronic liver disease, effect of imerferon alfa therapy. N. Engl. J. Med., 324, 933-940.
173. Collier, J.D., Guo, K., Gullick, W.J., Bassendine, M.F. and Burt, A.D. (1993) Expression of transforming growth factor alpha in human hepatocellular carcinoma. Liver, 13, 151-155.
174. Park, B.C., Hoh, M.H. and Seo, J.H. (1995) Differential expression of transforming growth factor α and insulin-like growth factor II in chronic active hepatitis B, cirrhosis and hepatocellular carcinoma. J. Hepatol., 22, 286-294.
175. Hsia, C.C., Axiotis, C.A., DiBisceglie, A.M. and Tabor, E. (1992) Transforming growth factor-alpha in human hepatocellular carcinoma and coexpression with heptitis B surface antigen in adjacent liver cancer. Cancer, 70, 1049-1056.
176. Morimitsu, Y., Hsia, C.C., Kojiro, M. and Tabor, E. (1995) Nodules of lessdifferentiated tumor within or adjacent to hepatocellular carcinoma, relative expression of transforming growth factor-α and its receptor in the different areas of rumor. Human Pathol., 26, 1126-1132.
177. Yeh, Y.-C., Tsai, J.-F., Chuang, L.-Y., Yeh, H.-W., Tsai, J.-H., Florine, L. and Tam, J.P. (1987) Elevation of transforming growth factor a and its relationship to the epidermal growth factor and α-fetoprotein levels in patients with hepatocellular carcinoma. Cancer Res., 47, 896-901.
178. Chuang, L.-Y, Tsai, J.-H., Yeh,Y.-C., Chang, C.-C, Yeh, H.-W., Guh, Y.-Y. and Tsai, J.-F. (1991) Epidermal growth factor-related transforming growth factors in the urine of patients with hepatocellular carcinoma, Hepatology, 13, 1112-1116.
179. Tomiya, T. and Fujiwara, K. (1996) Serum transforming growth factor α as a marker of hepatocellular carcinoma complicating cirrhosis. Cancer, 77, 1056-1060.
180. Ueno, T., Takahashi, K., Matsuguchi, T., Ikejiri, K., Endo, H. and Yamamoto, M. (1988) Reactivation of rat insulin-like growth factor II gene during hepatocarcinogenesis. Carcinogenesis, 9, 1779-1783.
181. Schirmacher, P., Held, W.A., Yang, D., Chisari, F.V., Rustum, Y. and Rogler, C.E. (1992) Reactivation of insulin-like growth factor II during hepatocarcinogenesis suggests a role in malignant growth. Cancer Res., 52, 2549-2556.
182. Jirtle, R.L., Hankins, R., Reisenbacher, H. and Boyer, I.J. (1994) Regulation of mannose 6-phosphate/insulin-like growth factor-II receptors and transforming growth factor beta during liver tumor promotion with phenobarbital. Carcinogenesis, 15, 1473-1478.
183. Rurnsby, P.C., Davies, M.J., Price, R.J. and Lake, B.G. (1994) Effect of some peroxisome proliferators on transforming growth factor-β gene expression and insulin-like growth factor II/mannose-6-phosphate receptor gene expression in rat liver. Carcinogenesis, 15, 419-421.
184. Cariani, E., Lasserre, C., Seurin, D., Hamelin, B., Kemeny, F., Franco, D., Czech, M.P., Ullrich, A. and Brechot, C. (1988) Differential expression of insulin-like growth factor II in RNA in human primary liver cancers, benign liver tumors and liver cirrhosis. Cancer Res., 48, 6844-6849.
185. Lamas, E., LeBail, B., Housset, C., Boucher, O. and Brechot, C. (1991) Localization of insulin-like growth factor-II and hepatitis B virus mRNAs and proteins in human hepatocellular carcinomas. Lab. Invest., 64, 98-104.
186. Fiorentino, M., Grigoni, W.F., Baccarini, P., D'Errico, A., DeMitri, M.S., Pisi, E. and Mancini, A.M. (1994) Different in situ expression of insulinlike growth factor type II in hepatoceUular carcinoma, an in situ hybridization and histochemical study. Diag. Mol. Pathol., 3, 59-65.
187. D'Arville, C.N., Nouri-Aria, K.T., Johnson, P. and Williams, R. (1991) Regulation of insulin-like growth factor II gene expression by hepatitis B virus in hepatocellular carcinoma. Hepatology, 13, 310-315.
188. Cariani, E., Lasserre, C., Kemeny, F., Franco, D. and Brechot, C. (1991) Expression of insulin-like growth factor II, α-fetoprotein and hepatitis B virus transcripts in human primary liver cancer. Hepatology, 13, 644-649.
189. Daughaday, W.H., Wu, J.-C., Lee, S.-D. and Kapadia, M. (1990) Abnormal processing of pro-IGF-II in patients with hepatoma and some hepatitis B virus antibody-positive asymptomatic individuals. J. Lab. Clin. Med., 115, 555-562.
190. Cariani, E., Seurin, D., Lasserre, C., Franco, D., Binoux, M. and Brechot, C. (1990) Expression of insulin-like growth factor II (IGF-II) in human primary liver cancer, mRNA and protein analysis. J. Hepatol., 11, 226-231.
191. Akmal, S.N., Yun, K., MacLay, J., Higami, Y. and Ikeda, T. (1995) Insulin-like growth factor 2 and insulin-like growth factor binding protein 2 expression in hepatoblastoma. Human Pathol., 26, 851-858.
192. Davies, S.M. (1993) Maintenance of genomic imprinting at the IGF2 locus in hepatoblastoma. Cancer Res., 53, 4781-4783.
193. Ranier, S., Dobry, C.J. and Feinberg, A.P. (1995) Loss of imprinting in hepatoblastoma. Cancer Res., 55, 1836-1838.
194. Li, X., Adam, G., Cui, H., Sandstedt, B., Ohlsson, R. and Ekström, T.J. (1995) Expression, promoter, usage and imprinting status of insulin-like growth factor II (IGF2) in human hepatoblastomas, uncoupling of IGF2 and H19 imprinting. Oncogene, 11, 221-229.
195. Sue, S.R., Chari, R.S., Kong, F.-M., Mills, J.J., Fine, R.L., Jirtle, R.L. and Meyers, W.C. (1995) Transforming growth factor beta receptors and mannose 6-phosphate/insulin-like growth factor-II receptor expression in human hepatocellular carcinomas. Ann. Surg., 222, 171-178.
196. DeSouza, A.T., Hankins, G.R., Washington, M.K., Fine, R.L., Orton, T.C. and Jmle, R.L. (1995) Frequent loss of heterozygosity on 6q at the mannose 6-phosphate receptor/insulin-like growth factor II receptor locus in human hepatocellular tumors. Oncogene, 10, 1725-1729.
197. DeSouza, A.T., Hankins, G.R., Washington, M.K., Orton, T.C. and Jirtle, R.L. (1995) M6P/IGF2R gene is mutated in human hepatocellular carcinoma with loss of heterozygosity. Nature Genet., 11, 447-449.
198. Rogler, C.E., Yang, D., Rossetti, L., Donohoe, J., Alt, E., Chang, C.J., Rosenfeld, R., Neely, K. and Hintz, R. (1994) Altered body composition and increased frequency of various malignancies in insulin-like growth factor-II transgenic mice. J. Biol. Chem., 269, 13779-13784.
199. Norgaard, P., Hougaard, S., Poulsen, H.S. and Spang-Thomsen, M. (1995) Transforming growth factor β and cancer. Cancer Treat. Rev., 21, 367-403.
200. Reisenbichler, H., Chari, R.S., Boyer, I.J. and Jirtle, R.L. (1994) Transforming growth factor-β receptors type I, II and III in phenobarbitalpromoted rat liver tumors. Carcinogenesis, 15, 2763-2767.
201. Ito, N., Kawata, S., Tamura, S., Takaishi, K., Shirai, Y., Kiso, S., Yabuuchi, I., Matsuda,Y., Nichioka, M and Tarui, S. (1991) Elevated levels of transforming growth factor β messenger RNA and its polypeptide in human hepatocellular carcinoma. Cancer Res., 51, 4080-4083.
202. Shira,Y., Kawata, S., Tamura, S., Ito, N., Tsushima, H., Takaishi, K., Kiso, S. and Matsuzawa, Y (1994) Plasma transforming growth factor-βl in patients with hepatocellular carcinorrfa. Comparison with chronic liver diseases. Cancer, 73, 2275-2279.
203. Strorn, S.C. and Faus, J.B. (1990) Oncogene activation and hepatocarcinogenesis. Pathobiology, 58, 153-167.
204. Deguchi,T. and Pitot, H.C. (1995) Expression of c-myc in altered hepatocyte foci induced in rats by various single doses of diethylnitrosamine and promotion by 0.05% phenobarbital. Mol. Carcinogenesis, 14, 152-159.
205. Himeno, Y., Fukuda,Y., Hatanaka, M. and fmura, H. (1989) Expression of oncogenes during rat chemical hepatocarcinogenesis. Japan. J. Cancer Res., 80, 737-742.
206. Ha proto-oncogenes during sex-differentiated rat liver carcinogenesis in the resistant hepatocyte model. Carcinogenesis, 10, 1793-1800.
207. Galand, P., Jacobovitz, D. and Alexandre, K. (1988) Immunohistochemical detection of c-Ha-ras oncogene p21 product in pre-neoplastic and neoplastic lesions during hepatocarcinogenesis in rats. Int. J. Cancer, 41, 155-161.
208. Sills, R.C., Goldsworthy, J.L. and Sleight, S.D. (1994) Tumor-promoting effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin and phenobarbital in initiated weanling Sprague-Dawley rats, a quantitative, phenotypic and ras p21 protein study. Toxicol. Pathol., 22, 270-281.
209. Suchy, B.K., Sarafoff, M., Ketier, R. and Rabes, H.M. (1989) Amplification, rearrangements and enhanced expression of c-myc in chemically induced rat liver tumors in vivo and in vitro. Cancer Res., 49, 6781-6787.
210. Chandar, N., Lombardi, B. and Locker, J. (1989) c-myc gene amplification during hepatocarcinogenesis by a choline-devoid diet. Proc. Natl Acctd. Sci. USA, 86, 2703-2707.
211. Bhave, M.B., Wilson, M.J. and Poirier, L.A. (1988) c-H-ras and c-K-raa gene hypomethylation in the livers and hepatomas of rats fed methyldeficient, amino acid-defined diets. Carcinogenesis, 9, 343-348.
212. Ray, J.S., Harbison, M.L., McClain, R.M. and Goodman, J.I. (1994) Alterations in the methylation status and expression of the raf oncogene in phenobarbital-induced and spontaneous B6C3F1 mouse liver tumors. Mol. Carcinogenesis, 9, 155-166.
213. Counts, J.L. and Goodman, J.I. (1993) Comparative analysis of the 5′ flanking region of Ha-ras in B6C3F1, C3H/He and C57BL/6 mouse liver. Cancer Lett., 75, 129-136.
214. Hansen, L.J., Tennant, B.C., Seeger, C. and Ganem, D. (1993) Differential activation of myc gene family members in hepatic carcinogenesis by closely related hepatitis B viruses. Mol Cell. Biol., 13, 659-667.
215. Yang, D., Alt, E. and Rogler, CE. (1993) Coordinate expression of N-myc 2 and insulin-like growth factor II in precancerous altered hepatic foci in woodchuck hepatitis virus carriers. Cancer Res., 53, 2020-2027.
216. Gu, J.-R., Hu, L.-F., Cheng, Y-C. and Wan, D.-F. (1986) Oncogenes in human primary hepatic cancer. J. Cell Physiol., 4(Suppl.), 13-20.
217. Himeno, Y., Fukuda, Y., Hatanaka, M. and Imura, H. (1988) Expression of oncogenes in human liver disease. Liver, 8, 208-212.
218. Zhang, X.-K., Huang, D., Qiu, D.-K. and Chiu, J. (1990) The expression of c-myc and c-N-ras in human cirrhotic livers, hepatocellular carcinomas and liver tissue surrounding the tumors. Oncogene, 5, 909-914.
219. Abou-Elella, A., Gramlich, T., Fritsch, C. and Gansler, T. (1996) c-myc amplification in hepatocellular carcinoma predicts unfavorable prognosis. Mod. Pathol., 9, 95-98.
220. Kaneko, Y, Shibuya, M., Nakayama, T., Hayashida, N., Toda, G., Endo, Y., Oka, H. and Oda,T. (1985) Hypomethylation of c-myc and epidermal growth factor receptor genes in human hepatocellular carcinoma and fetal liver. Japan. J. Cancer Res., 76, 1136-1140.
221. Taylor, J.A., Bell, D.A. and Nagomey, D. (1993) L-myc proto-oncogene alleles and susceptibility to hepatocellular carcinoma. Int, J. Cancer, 54, 927-930.
222. Nonomura, A., Ohta, G., Hayashi, M., Izumi, R., Watanabe, K., Takayanagi, N., Mizukami, Y. and Matsubara, F. (1987) Zmmunohistochemical detection of ras oncogene p21 product in liver cirrhosis and hepatocellular carcinoma. Am. J. Gastroenterol., 82, 512-518.
223. Radosevich J.A., Gould, K.A., Koukoulis, G.K., Haines, G,K., RoSen, S.T., Lee, I. and Gould, V.E. (1993) Immunolocalization of ras oncogene p21 in human liver diseases, Ultrastruct. Pathol., 17, 1-18.
224. Murakami, H., Sanderson, N.D., Nagy, P., Marino, P., Merlino, G. and Thorgeirsson, S.S. (1993) Transgenic mouse model for synergistic effects of nuclear oncogenes and growth factors in turnorigenesis, interaction of c-myc and transforming growth factor α in hepatic oncogenesis. Cancer Res., 53, 1719-1723.
225. deThé, H., Marchio, A., Tiollais, P. and Dejean, A. (1987) A novel steroid thyroid hormone receptor-related gene inappropriately expressed in human hepatocellular carcinoma. Nature, 330, 667-670.
226. Boix, L., Rosa, J.L., Ventura F., Castells, A., Bruix, J., Rodés, J. and Bartrons,R. (1994) c-met RNA overexpression in human hepatocellular carcinoma. Hepatology, 19, 88-91.
227. Suzuki, K., Hayashi, N., Yamada,Y. et al. (1994) Expression of the c- met protooncogene in human hepatocellular carcinoma. Hepatology, 20, 1231-1236.
228. Grigoni, W.F., Fiorentino, M., D'Errico, A., Ponzetto, A., Crepaldi, T., Prat, M. and Comoglio, P.M. (1995) Overexpression of c-met protooncogene product and raised Ki67 index in hepatocellular carcinoma with respect to benign liver conditions, Hepatology, 21, 1543-1546.
229. Brunt, E.M. and Swanson, P.E. (1992) Immunoreactivity for c-erbB-2 oncopeptide in benign and malignant diseases of the liver. Am. J. Clin. Pathol., 97(Suppl.1), s53-s61.
230. Luo, J.-C, Yu, M.-W., Chen, C.-J., Santella, R.M., Carney, W.P. and Brandt-Rauf, PW. (1993) Serum c-erbB-2 oncopeptide in hepatocellular carcinogenesis. Med. Sci. Res., 21, 305-307.
231. Sever, C. and Locker, J. (1991) Expression of retinoic acid α and βreceptor genes in liver and hepatocellular carcinoma. Mol. Carcinogenesis, 4, 138-144.
232. Huang, L.-R. and Hsu, H.-C. (1995) Cloning and expression of CD24 gene in human hepatocellular carcinoma, a potential early tumor marker gene correlates with p53 mutation and tumor differentiation. Cancer Res., 55, 4717-4721.
233. Zhang, YJ., Tiang, W., Chen, C.J., Lee, C,S., Kahn, S.M., Santella, R.M. and Weinstein, B.I., (1993) Amplification and overexpression of cyclin Dl in human hepatocellular carcinoma. Biochem. Biophys. Res. Common., 196, 1010-1012.
234. Nishida, N., Fukuda, Y., Komeda, T., Kita, R., Sando, T., Nakao, K., Ikenaga, M. and Ishizaki, K. (1994) Amplification and overexpression of cyclin Dl gene in aggressive human hepatocellular carcinoma. Cancer Res., 54, 3107-3110.
235. Maronpot, R.R., Fox, T., Malarkey, D.E. and Golds worthy, T.L. (1995) Mutations in the ras proto-oncogene, clues to etiology and molecular pathogenesis of mouse liver tumors. Toxicol., 101, 125-156.
236. 1induced rat liver tumors. Proc, Natl Acad. Sci. USA, 87, 1104-1108.
237. Ostermayr, R., Suchy, B. and Rabes, H.M. (1991) Carcinogen-induced liver tumors of Wistar rats, absence of activated ras genes and of N-rasC. J. Cancer Res., clin. Oncol., 117, 381-384.
238. Tokushima, Y., Fukuda, I. and Ogawa, K. (1994) Absence of p53 mutations and various frequencies of Ki-ras exon 1 mutations in rat hepatic tumors induced by different carcinogens. Mol. Carcinogenesis, 10, 45-51.
239. Sinha, S., Webber, C., Marshall, C.J., Knowles, M.A., Proctor, A., Barass, N.C. and Neal, G.E. (1988) Activation of ras oncogenes in aflatoxin-induced rat liver carcinogenesis. Proc. Natl Acad. Sci. USA, 85, 3673-3677.
240. Stowers, S.J., Wiseman, R.W., Ward, J.M., Miller, E.C., Miller, J.A., Anderson, M.W. and Eva, A. (1988) Detection of activated proto-oncogenes in N-nitrosodiethylamine-induced liver tumors, a comparison between B6C3F1 mice and Fischer 344 rats. Carcinogenesis, 9, 271-276.
241. Watatani, M., Perantoni, A.O., Reed, C.D., Enomoto, T., Wenk, M.L. and Rice, J.M. (1989) Infrequent activation of K-ras, H-ras and other oncogenes in hepatocellular neoplasias initiated by methyl(acetoxyittethyl)-nitrosamine, a methylating agent and promoted by phenobarbital in F344 rats. Cancer Res., 49, 1103-1109.
242. Funato, T., Yokota, J., Sakamoto, H., Kameya, T., Fukushima, S., Ito, N., Terada, M. and Sugimura, T. (1987) Activation of N-ras gene in a rat hepatocellular carcinoma induced by diethylnitrosamine and butylated hydroxytoluene- Japan. J. Cancer Res., 78, 689-694.
243. Buchmann, A., Bauer-Hoffman, R., Mahr, J., Drinkwater, N.R., Luz, A. and Schwarz, M. (1991) Mutational activation of the c-Ha-ras gene in liver tumors of different rodent strains, correlation with susceptibility to hepatocarcinogenesis. Proc. Natl Acad. Sci. USA, 88, 911-915.
244. Ishikawa, F., Takaku, F., Nagao, M., Ochiai, M., Hayashi, K., Takayama, S. and Sugimura,T. (1985) Activated oncogenes in a rat hepatocellular carcinoma induced by 2-amino-3-methyl-imidazo(4,5-f)qmnoline. Japan. J. Cancer Res., 76, 425-428.
245. Li, H., Lee, G.-H., Liu, J., Nomura, K., Ohtake, K. and Kitagawa,T. (1991) Low frequency of ras activation in 2-acetylaminofluorene- and 3′-methyl-4-(dimethylamino) azobenzene-induced rat hepatocellular carcinomas. Cancer Lett., 56, 17-24.
246. Tsuda, H., Hirohashi, S., Shimosato, Y., Ino, Y., Yoshida, T. and Terada, M. (1989) Low incidence of point mutations of c-Ki-ros and N-ras oncogenes in human hepatocellular carcinoma. Japan. J. Cancer Res., 80, 196-199.
247. Tada, M., Omata, M. and Ohto, M. (1990) Analysis of ras gene mutations in human hepatic malignant tumors by polymerase chain reaction and direct Sequencing. Cancer Res., 50, 1121-1124.
248. Ogata, N., Kamimura, T. and Asakura, H. (1991) Point mutation allelic loss and increased methylation of the c-Ha-ras gene in human hepatocellular carcinoma. Hepatology, 13, 31-37.
249. Ochiya, T., Fujiyama, A., Fukushige, S., Hatada, I. and Matsubara, K. (1986) Molecular cloning of an oncogene from a human hepatocellular carcinoma. Proc. Natl Acad. Sci. USA, 83, 4993-4997.
250. Wang, J., Chenvesee, X., Henglein, B. and Bréchot,C. (1990) Hepatitis B virus integration in a cyclin A gene in hepatocellular carcinoma. Nature, 343, 555-557.
251. Tamori, A., Nishigachi, S., Kuroki, T., Koh, N., Kobayashi, L., Yano, Y. and Otani, S. (1995) Point mutation of ornithine decarboxylase gene in human hepatocellular Carcinoma. Cancer Res., 55, 3500-3503.
252. Watanabe, H., Fukuchi, K., Takagi, Y., Tomoyasu, S., Tsuruoka, N. and Gomi, K. (1995) Molecular analysis of Cipl/Wafl (p21) gene in diverse types of human tumors. Biochim. Biophys. Acta, 1263, 275-280.
253. Qin, L.-X., Tang, Z.-Y., Liu, K.-D., Ye, S.-L., He, B., Zhang, Y. and Zhou, G. (1996) Alterations of CDKN2 (p16/MTSl) exon 2 in human hepatocellular carcinoma. Oncology Rep., 3, 405-408.
254. Greenhlatt, M.S., Bennett, W.P., Hollstein, M. and Harris, C.C. (1994) Mutations in the p53 tumor suppressor gene, clues to cancer etiology and molecular pathogenesis, Cancer Res., 54, 4855-4878.
255. Hsu, I.C., Metcalf, R.A., Sun, T., Welsh, J.A., Wang, N.J. and Harris, C.C. (1991), Mutational hotspot in the p53 gene in human hepatocellular carcinoma. Nature, 350, 427-428.
256. Scorsone, K.A., Zhou, Y.-Z., Butel, J.S. and Seagel, B.L. (1992) p53 mutations cluster at codon 249 in hepatitis B virus-positive hepatocellular carcinomas from China, Cancer- Res., 52, 1635-1638.
257. Fujimoto, Y., Hampton, L.L., Wirth, PJ., Wang, N.J., Xie, J.P. and Thorgeirsson, S.S. (1994) Alterations of tumor suppressor genes and allelic losses in human hepatocellular carcinoma from China. Cancer Res., 54, 281-285.
258. Bressac, B., Kew, M., Wands, J. and Ozturk, M. (1991) Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature, 350, 429-131.
259. Unsal, H., Yakicier, C., Marcais, C., Kew, M., Volkmann, M., Zentgraf, H., Isselbacher, K.J. and Ozturk, M. (1994) Genetic heterogeniety of hepatocellular carcinoma Proc. Natl Acad. Sci. USA, 91, 822-826.
260. Ozturk, M. and 28 collaborators (1991) p53 mutations and hepatocellular carcinoma after aflatoxin exposure. Lancet, 338, 1356-1359.
261. Hosono, S., Lee, C.-S., Chou, M.-J. Yang, C.-S. and Shih, C. (1991) Molecular analysis of the p53 alleles in primary hepatocellular carcinomas and cell lines. Oncogene, 6, 237-243.
262. Murakami, Y., Hayashi, K., Hirohashi, S. and Selliya, T. (1991) Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinoma. Cancer Res., 51, 5520-5525.
263. Oda, T., Tsuda, H., Scarpa, A., Sakamoto, M. and Hirohashi, S. (1992) p53 gene mutation in hepatocellular carcinoma. Cancer Res., 52, 6358-6364.
264. 1 exposure in hepatocellular carcinoma patients from Thailand, Int. J. Cancer, 53, 51-55.
265. Hosono, S., Chou, M.-J., Lee, C.-S. and Shih, C. (1993) Infrequent mutation of p53 gene in hepatitis B virus positive primary hepatocellular carcinoma. Oncology, 8, 491-496.
266. Nishida, N., Fukuda, Y., Kokuryu, H., Toguchida, J., Yandell, D.W., Ikenaga, M., Imura, H. and Ishizaki, K. (1993) Role and mutational heterogeneity of the p53 gene in hepatocellular carcinoma. Cancer Res., 53, 368-372.
267. Nose, H., Imazeki, F., Ohto, M. and Omata, M. (1993) p53 gene mutations and 17p allelic deletions in hepatocellular carcinoma from Japan. Cancer, 72, 355-360.
268. Teramoto, T., Satonaka, K., Kitazawa, S., Fujimori, T., Hayashi, K. and Maeda, S. (1994) p53 gene abnormalities are closely related to hepatoviral infections and occur in a late stage of hepatocarcinogenesis. Cancer Res., 54, 231-235.
269. Hayashi, H., Sugio, K., Matsumata, T., Adachi, E., Takenaka, K. and Sugimachi, K. (1995) The clinical significance of pS3 gene mutation in hepatocellular carcinomas in Japan. Hepatology, 22, 1702-1707.
270. Shi, C.Y., Phang, T.W., Lin, Y., Wee, A., Li, B., Lee, H.P. and Ong, C.N. (1995) Codon 249 mutation of the p53 gene is a rare event in hepatocellular carcinomas from ethnic Chinese in Singapore. Brit. J. Cancer, 72, 146-149.
271. Kress, S., Jahn, U.-R., Buchmann, A., Bannasch, P. and Schwarz, M. (1992) p53 mutations in human hepatocellular carcinomas from Germany. Cancer Res., 52, 3220-3223.
272. Debuire, B., Paterlini, P., Pontisso, P., Basso, B. and May, E. (1993) Analysis of the p53 gene in hepatocellular carcinomas and hepatoblastomas. Oncogene, 8, 2303-2306.
273. Kubicka, S., Trautwein, C., Schrem, H., Tillmann, H. and Manns, M. (1995) Low incidence of p53 mutations in European hepatocellular carcinomas with heterogeneous mutation as a rare event. J. Hepatology, 23, 412-419.
274. Kar, S., Jaffe, R. and Carr, B.I. (1993) Mutation at codon 249 of p53 gene in a human hepatoblastoma. Hepatology, 18, 566-569.
275. Shieh, Y.S.C., Nguyen, C., Vocal, M.V. and Chu, H.-W. (1993) Tumorsuppressor p53 gene in hepatitis C and B virus-associated hepatocellular carcinoma. Int. J, Cancer, 54, 558-562.
276. Andersson, M., Jönsson, M., Nielsen, L.L., Vyberg, M., Visfeldt, J., Storm, H.H. and Wallin, H. (1995) Mutations in the tumor suppressor gene p53 in human liver cancer induced by ̈-particles. Cancer Epid. Biomark. Prev., 4, 765-770.
277. DiBenedetti, V.M.G., Welsh, J.A., Trivers, G.E., Harpster, A., Parkinson, A.J., Lanier, A.P., McMahon, B.J. and Bennett, W.P. (1995) p53 is not mutated in hepatocellular carcinomas in Alaskan natives. Cancer Epid. Biomark. Prev., 4, 79-82.
278. DiBenedetti, V.M.G., Welsh, J.A., Yu, M.C. and Bennett, W.p. (1996) p53 mutations in hepatocellular carcinoma related to oral contraceptive use, Carcinogenesis, 17, 145-149.
279. Bjersing, L., Andersson, C. and Lithner, F. (1996) Hepatocellular carcinoma in patients from northern Sweden with acute intermittent porphyria, morphology and mutations. Cancer Epidem. Biomark. Prev., 5, 393-397.
280. Kennedy, S.M., MacGeogh, C, Jaffe, R. and Spurr, N.K. (1994) Overexpression of the oncoprotein p53 in primary hepatic tumors of childhood does not correlate with gene mutations. Human Pathol., 25, 438-442.
281. Ng, I.D.L., Srivastava, G., Chung, L.P., Tsang, S.W.Y. and Ng, M.M.T. (1994) Overexpression and point mutation of p53 tumor suppressor gene in hepatocellular carcinomas in Hong Kong Chinese people. Cancer, 74, 30-37.
282. Livni, N., Eid, A., IIan, Y., Rivkind, A., Rosenman, E., Blendis, L.M., Shouval, D. and Galun, E. (1995) p53 expression in patients with cirrhosis with and without hepatocellular carcinoma. Cancer, 75, 2420-2426.
283. Nakopoulou, L., Janinis, J., Giannopoulou, I., Lazaris, A.C., Koureas, A. and Zacharoulis, D. (1995) Immunohistochemical expression of p53 protein and proliferating cell nuclear antigen in hepatocellular carcinoma. Pathol. Res. Pract., 191, 1208-1213.
284. Aquilar, F., Harris, C.C., Sun, T., Hollstein, M. and Cerutti, P. (1994) Geographic variation of p53 mutational profile in nonmalignant human liver. Science, 264, 1317-1319.
285. Nishida, N., Fukada, Y., Kokuryu, H. et al. (1992) Accumulation of allelic loss on arms of chromosomes 13q, 16q and 17p in advanced stages of human hepatocellular carcinoma. Int. J. Cancer, 51, 862-868.
286. Konishi, M., Kikuchi-Yanoshita, R., Tanaka, K. et al. (1993) Genetic changes in human hepatocellular carcinomas. Japan. J. Cancer Res., 84, 893-899.
287. Tanaka, S., Toh, Y., Adachi, E., Matsumata, T., Mori, R. and Sugimachi, K. (1993) Tumor progression in hepatocellular carcinoma may be mediated by p53 mutation. Cancer Res., 53, 2884-2887.
288. Hsu, H.-C., Peng, S.-Y., Lai, P.-L., Sheu, J.-C., Chen, D.-S., Lin, L.-L., Slagle, B.L. and Butel, J.W. (1994) Allelotype and loss of heterozygosity of p53 in primary and recurrent hepatocellular carcinomas. A study of 150 patients. Cancer, 73, 42-47.
289. Kuroki, T., Fujiwara, Y., Tsuchiya, E., Nakamori, S., Imaoka, S., Kanematsu, T. and Nakamura, Y. (1995) Accumulation of genetic changes during development and progression of hepatocellular carcinoma, loss of heterozygosity on chromosome Ip occurs at an early stage of hepatocarcinogenesis. Genes, Chrom. Cancer, 13, 163-167.
290. Slagle, B.L., Zhou, Y.-Z. and Butel, J.S. (1991) Hepatitis B virus integration event in human chromosome 17p near p53 gene identifies the region of the chromosome commonly deleted in virus-positive hepatocellular carcinomas. Cancer Res., 51, 49-54.
291. Ding, S.-F., Habib, N.A., Dooley, J., Wood, C. and Habib, N.A. (1991) Loss of constitutional heterozygosity on chromosome 5q in hepatocellular carcinoma without cirrhosis. Brit. J. Cancer, 64, 1083-1087.
292. Fujimori, M., Tokino, T. and Hino, O. (1991) Allelotype study of primary hepatocellular carcinoma. Cancer Res., 51, 89-93.
293. Walker, G.J., Hayward, N.K., Falvey, S. and Cooksley, W.G.E. (1991) Loss of somatic heterozygosity in hepatocellular carcinoma. Cancer Res., 51, 4367-4370.
294. Malkin, D. (1994) p53 and the Li-Fraumeni syndrome. Biochim. Biophys. Acta, 1198, 197-213.
295. Oda, H., Nakatsuru, Y., Imai, Y., Sugiraura,H. and Ishikawa. T. (1995) A mutational hotspot in the p53 gene is associated with hepatoblastomas. Int. J. Cancer, 60, 786-790.
296. Zhang, X., Xu, H.-J., Murakami, Y., Sachse, R., Yashima, K., Hirohashi, S., Hu, S.-X., Benedict, W.F. and Sekiya,T. (1994) Deletions of chromosome 13q, mutations in Retinoblastoma 1 and retinoblastoma protein in human hepatocellular carcinoma. Cancer Res., 54, 4177-4182.
297. Wang, H.P. and Rogler, C.E. (1988) Deletion in human chromosome arms 11p and 13q in primary hepatocellular carcinomas. Cytogenet. Cell Genet., 48, 72-78.
298. Beutow, K.H., Murray, J.C., Israel, J.L., London, W.T., Smith, M., Kew, M., Blanquet, V., Redeker, A. and Govindarajah, S. (1989) Loss of heterozygosity suggests tumor suppressor gene responsible for primary hepatocellular carcinoma. Proc. Natl Acad. Sci. USA, 86, 8852-8856.
299. Abramson, D.H., Ellsworth, R.M., Kitchin, F.D. and Tung,G. (1984) Second nonocular tumors in retinoblastoma survivors. Are they radiation-induced? Ophthalmology, 91, 1351-1355.
300. Meadows, A.T., Baum, E., Fossati-BeIlani, F. etal. (1985) Second malignant neoplasms in children, an update from the late effects study group. J. Clin. Oncol., 3, 532-538.
301. Breslow, N.E., Norkool, P.A., Olshan, A., Evans, A. and D'Angio, G.J. (1988) Second malignant neoplasms in survivors of Wilms' tumors, a report of the National Wilms' Tumor Study Group. J. Natl Cancer Inst., 80, 592-595.
302. Koufos, A., Hansen, M.F., Copeland, N.G., Jenkins, N.A., Lampkin, B.C. and Cavanee, W.K. (1985) Loss of heterozygosity in three embryonal tumors suggests a common pathogenic mechanism. Nature, 316, 330-334.
303. Rogler, C.E., Sherman, M., Su, C.Y., Summers, J., Shows, T.B., Henderson, A. and Kew, M. (1985) Deletion in chromosome 11p associated with a hepatitis B integration site in hepatocellular carcinoma. Science, 230, 319-322.
304. Little, M.H., Thomson, D.B., Hayward, N.K. and Smith, P.J. (1988) Loss of alleles on the short arm of chromosome 11 in a hepatoblastoma from a child with Beckwith-Wiedemann syndrome. Human Genet., 79, 186-189.
305. Byrne, J.A., Simms, L.A., Little, M.H., Algar, E.M. and Smith, P.J. (1993) Three non-overlapping regions of chromosome arm lip allele loss identified in infantile tumors of adrenal and liver. Genes. Chrom. Cancer, 8, 104-111.
306. Albrecht, S., von Schweinitz, D., Waha, A., Kraus, J.A., von Deimling, A. and Pietsch,T. (1994) Loss of maternai alleles on chromosome arm 11p in hepatoblastoma. Cancer Res., 54, 5041-5044.
307. Iwama,T. and Michiwa,Y. (1994) Mortality in young first-degree relatives of patients with familial adenomatous polyposis. Cancer, 73, 2065-2068.
308. Oda, H., Imai, Y., Nakatsuru,Y., Hata, J. and Ishikawa,T. (1996) Somatic mutations of the APC gene in sporadic hepatoblastoma. Cancer Res., 56, 3320-3323.
309. Simon, D., Knowles, B.B. and Werth, A. (1991) Abnormalities of chromosome 1 and loss of heterozygosity on Ip in primary hepatomas. Oncogene, 6, 765-770.
310. Yeh, S.-H., Chen, R.J., Chen, H.-L., Lai, M.-Y., Wang, C.-C. and Chen, D.-S. (1994) Frequent genetic alterations at the distal region of chromosome 1p in human hepatocellular carcinoma. Cancer Res., 54, 4188-4192.
311. Simon, D. and Carr, B.I. (1995) Integration of hepatitis B virus and alteration of the 1p36 region found in cancerous tissue of primary hepatocellular carcinoma with viral replication evidenced only in noncancerous. cirrhotic tissue. Hepatology, 22, 1393-1398.
312. Pasquinelli,C., Garreau,F., Bouquelleret, L. et al. (1988) Rearrangement of a common cellular DNA domain on chromosome 4 in primary liver tumors. J. Virol., 62, 629-632.
313. Zhang,W., Hirohashi, S., Tsuda, H., Shimosato,Y., Yokota, J., Terada, M. and Sunmura,T. (1990) Frequent loss of heterozygosity on chromosomes 16 and 4 in human hepatocellular carcinoma. Japan. J. Cancer Res., 81, 108-111.
314. Yeh, S.-W., Chen, P.-J., Lai, M.-Y and Chen, D.-S. (1996) Allelic loss on chromosomes 4q and 16q in hepatocellular carcinoma, association with elevated α-fetoprotein production. Gastroenterology, 110, 184-192.
315. Emi, M., Fujiwara,Y., Nakajima, T. et al. (1992) Frequent loss of heterozygosity for loci on chromosome 8p in hepatocellular carcinoma, colorectal cancer and lung cancer. Cancer Res., 52, 5368-5372.
316. Fujiwara, Y., Monden, M., Mori, T., Nakamura, Y. and Emi,M. (1993) Frequent multiplication of the long arm of chromosome 8 in hepatocellular carcinoma. Cancer Res., 53, 857-860.
317. Takahashi, K., Kudo, J., Ishibashi, H., Hirata, Y. and Niho, Y (1993) Frequent loss of heterozygosity on chromosome 22 in hepatocellular carcinoma. Hepatology, 17, 794-799.
318. Tsuda, H., Zhang, W., Shimosato, Y., Yokota, J., Terada, M., Suzimura, T., Miyamura, T. and Hirohashi, S. (1990) Allele loss on chromosome 16 associated with progression of human hepatocellular carcinoma. Proc. Natl Acad. Sci. USA, 87, 6791-6794.
319. Slagle, B.L., Zhou, Y.-Z., Birchmeier, W. and Scorsone, K.A. (1993) Deletion of the E-cadherin gene in hepatitis B virus-positive Chinese hepatocellular carcinoma. Hepatology, 18, 757-762.
320. Simon, D., Munoz, S.J., Maddrey, W.D. and Knowles, B.B. (1990) Chromosomal rearrangements in a primary hepatocelluiar carcinoma. Cancer, Genet. Cytogenet., 45, 255-260.
321. Chen, H.-L., Chen, Y.-C. and Chen, D.-S. (1996) Chromosome 1p aberrations are frequent in human primary hepatoceuular carcinoma. Cancer, Genet. Cytogenet., 86, 102-106.
322. Hino, C., Shows, R. and Rogler, C.E. (1986) Hepatitis B virus integration site in hepatocellular carcinoma at chromosome 17, 18 translocation. Proc. Natl Acad. Sci. USA, 83, 8338-8342.
323. Tokino, T., Fukushiga, S., Nakamura, T., Nagaya, T., Murotsu, J., Shiga, K., Aoki, N. and Matsubara, K.(1987) Chromosome translocation and inverted duplication with integrated hepatitis B virus in hepatocellular carcinoma. J. Virol., 61, 3848-3854.
324. Meyer, M., Wiedorn, K.H., Hofschneider, P.H., Koshy, R. and Caselman, W.H. (1992) A chromosome 17, 7 translocation is associated with a hepatitis B virus integration site in hepatocellular carcinoma DNA. Hepatology, 15, 665-671.
325. Kimura, H., Kagawa, K., Deguchi, T. et al (1996) Cytogenetic analysis of hepatocellular carcinoma by in situ hybridization with a chromosome-specific DNA probe. Cancer, 77, 271-277.
326. Nagai, H., Ponglikitmongkel, M., Mita, E., Omachi, Y., Yoshikawa, H., Saeki, R., Yumoto, Y., Nakanishi, T. and Matsubara,K. (1994) Aberration of genomic DNA in association with hepatocellular carcinoma detected by 2-dimensional gel analysis. Cancer Res., 54, 1545-1550.
327. Haas, O.A., Zoubek, A., Grümayer, E.R. and Gadner, H. (1986) Constituional interstitial deletion of 11p11 and a pericentric inversion of chromosome 9 in a patient with Wiedemann-Beckwith syndrome and hepatoblastoma. Cancer, Genet. Cytogenet., 23, 95-104.
328. Tonk, V.S., Wilson, K.S., Timmons, C.F. and Schneider, N.R. (1994) Trisomy 2, Trisomy 20 and del(17p) as sole chromosomal abnormalities in three cases of hepatoblastoma. Genes. Chromo. Cancer, 11, 199-202.
329. Matsubara, K. and Tokino, T. (1990) Integration of hepatitis B virus DNA and its implication for hepatocarcinogenesis. Mol. Biol. Med., 7, 243-260.
330. Ding, S.-F., Dellhanty, J.D.A., Carillo, A., Delia Serra, G., Bowles, L. and Dooley, J.S. (1993) Lack of demonstrable chromosome allele loss in hepatocellular adenoma. Mr. J. Oncol, 2, 977-979.
331. Ding, S.-F, Jalleh, R.P., Dooley, J., Wood, C.B. and Habib, N.A. (1991) Chromosome 17 allele loss in hepatocellular carcinoma but not in synchronous hepatocellular adenoma. Eur. J. Surg. Oncol., 19, 195-197.
332. Rivkina, M.B., Cullen, J.M., Robinson, W.S. and Marion, P.L. (1994) State of the p53 gene in hepatocellular carcinomas of ground squirrels and woodchucks with past and ongoing infections with hepadna viruses. Cancer Res., 54, 5430-5437.
333. 1-induced rat hepatic hyperplastic nodules do not exhibit a site-specific mutation within the p53 gene. Cancer Res., 53, 9-11.
334. 1. Mol. Carcinogenesis, 6, 159-172.
335. 1 in non-human primates. Cancer Res., 52, 1044-1046.
336. Fujimoto, Y., Hampton, L.L., Snydenvine, E.G., Nagao, M., Sugimura, T., Adamson, R.H. and Thorgeirsson, S.S. (1994) p53 gene mutation and hepatocellular carcinoma induced by 2-amino-3-methylimidazo(4,5-f)quinoline in nonhuman primates. Japan. J. Cancer Res., 85, 506-509.
337. Smith, M.L., Yeleswarapu, L., Locker, J. and Lombardi, B. (1991) Expression of p53 mutant protein(s) in diethylnitrosamine-induced foci of enzyme-altered hepatocytes in mal Fischer-344 rats. Carcinogenesis, 12, 1137-1141.
338. Wirnitzer, U., Enzmann, H., Rosenbruch, M. and Bombard, E.M. (1995) Accumulation of p53 protein in chemically induced oval cells during early stages of rodent hepatocarcinogenesis. Carcinogenesis, 16, 697-701.
339. Ho, Y.-S., Cheng, H.-T., Wang, Y.-J. and Lin, J.-K. (1995) p53 gene mutational spectra in hepatocellular carcinomas induced by 2-acetylaminofluorene and N-nitroso-2-acetylaminofluorene in rats. Mol. Carcinogenesis, 13, 182-190.
340. Smith, M.L., Yeleswarapu, L., Scalamogna, P., Locker, J. and Lombardi, B. (1993) p53 mutations in hepatocellular carcinomas induced by a choline-devoid diet in male Fischer 344 rats. Carcinogenesis, 14, 503-510.
341. Fukada, I. and Ogawa, K. (1993) Detection of p53 gene mutations in rat hepatocellular carcinoma cell lines by denaturing gradient gel electrophoresis (DGGE). Mol. Carcinogenesis, 7, 257-262.
342. Smith, M.L., Yeleswarapu, L., Lombardi, B. and Shinozuka, H. (1993) Lack of mutations in the p53 tumor suppressor gene in hepatocellular carcinomas induced in rats by a peroxisome proliferator. Mol. Carcinogenesis, 7, 89-93.
343. Goodrow, T.L., Storer, R.D., Leander, K.R., Prahalada, S.R., vanZwieten, M.J. and Bradley, M.O. (1992) Murine p53 intron sequences 5-8 and their use in polymerase chain reaction/direct sequencing analysis of p53 mutations in CD-1 mouse liver and lung tumors. Mol. Carcinogenesis, 5, 9-15.
344. Kress, S., König, J., Schweizer, J., Löhrke, H., Bauer-Hoffmann, R. and Schwarz, M. (1992) p53 mutations are absent from carcinogen-induced mouse liver tumors but occur in cell lines established from these tumors. Mol. Carcinogenesis, 6, 148-158
345. Rumsby, P.C., Davies, M.J. and Evans, J.G. (1994) Screening for p53 mutations in C3H/He mouse liver tumors derived spontaneously or induced with diethylnitrosamine or phenobarbitone. Mot. Carcinogenesis, 9, 71-75.
346. Calvert, R.J., Toshiro, Y., Buzard, G.S., Diwan, B.A. and Weghorst, C.M. (1995) Lack of p53 point mutations in chemically induced mouse hepatoblastomas, an end-stage, highly malignant hepatocellular tumor. Cancer Lett., 95, 175-180.
347. Harvey, M., Vogel, H., Morris, D., Bradley, A., Bernstein, A. and Donehower, L.A. (1995) A mutant p53 transgene accelerates tumor development in heterozygous but not nullizygous p53-deficient mice. Nature Genet., 9, 305-311.
348. Kemp, C.J. (1995) Hepatocarcinogenesis in p53-deficient mice. Mol. Carcinogenesis, 12, 132-136.
349. Smith, M.L., Chandar, N. and Lombardi, B. (1993) Low frequency of retinoblastoma gene alterations in rat hepatocellular carcinomas. Mol. Carcinogenesis, 8, 228-233.
350. Δ20/+ mice are predisposed to tumors of the pituitary gland with nearly complete penetrance. Oncogene, 9, 1021-1027.
351. Williams, B.D., Remington, L., Albert, D.M., Mukai, S., Bronson, R.T. and Jacks, T. (1994) Cooperative tumorigenic effects of germ line mutations in Rb and p53. Nature Genet., 7, 480-484.
352. Davis, L.M., Caspary, W.J., Sakallah, S.A., Maronpot, R., Wiseman, R., Barrett, J.C., Elliott, R. and Hozier, J.C. (1994) Loss of heterozygosity in spontaneous and chemically induced tumors of the B6C3F1 mouse. Carcinogenesis, 15, 1637-1645.
353. Miyasaka, K., Ohtake, K., Nomura, K., Kanda, H., Kominami, R., Miyashita, N. and Kitagawa, T. (1995) Frequent loss of heterozygosity on chromosome 4 in diethylnitrosamine-induced C3H/MSM mouse hepatocettular carcinomas in culture. Mol. Carcinogenesis, 13, 37-43.
354. Manenti, G., DeGregorio, L., Gariboldi, M., Dragani, T. and Pierotti, M.A. (1995) Analysis of loss of heterozygosity in murine hepatocellular tumors. Mol. Carcinogenesis, 13, 191-200.
355. Held, W.A., Pazik, J., O'Brien, J.G., Kerns, K., Gobey, M., Meis, R., Kenny, L. and Rustum, Y. (1994) Genetic analysis of liver tumorigenesis in SV40 T antigen transgenic mice implies a role for imprinted genes. Cancer Res., 54, 6489-6495.
356. Ohsumi, T., Okazaki, Y., Okuizumi, H. et al. (1995) Loss of heterozygosity in mouse hepatoma detected by systematic genome-wide scanning using RLGS genetic map. Biochem. Biophys. Res. Commun., 212, 632-639.
357. Sargent, L.M., Sanderson, N.O. and Thorgeirsson, S.S. (1996) Ploidy and karyotypic alterations associated with early events in the development of hepatocarcinogenesis in transgenic mice harboring c-myc and transforming growth factor a transgenes. Cancer Res., 56, 2137-2142.
358. Herens, C., Alvarez Gonzalez, M.L. and Barbason, H. (1992) Cytogenetic changes in hepatocarcinomas from rats treated with chronic exposure to diethylnitrosamine. Cytogenet. Cell Genet., 60, 45-52.
359. Sargent, L.M., Sattler, G.L., Roloff, B., Xu, Y.-H., Sattler, C.L., Meisner, L and Pitot, H.C. (1992) Ploidy and specific karyotypic changes during promotion with phenobarbital, 2,5,2′,5′-tetrachlorobiphenyl and/or 3,4,3′,4′-tetrachlorobiphenyl in rat liver. Cancer Res., 52, 955-962.
360. Steadman, J.S., Lee, L.W., Smith, G.J. and Grisham, J.W. (1994) DMA contents and chromosomes of transformed rat liver epithelial cells and of cells from their derived tumors. Carcinogenesis, 15, 963-969.
361. Levan, G., Szpirer, J., Szpirer, C., Klinga, K., Hanson, C. and Islam, M.Q. (1991) The gene map of the Norway rat (Rattus norvegicus) and comparative mapping with mouse and man. Genomics, 10, 699-718.
362. Coleman, W.B., McCullough, K.S., Esch, G.L., Civalier, C.J., Livanos, E., Weissman, B.E., Grisham, J.W. and Smith, G.J. (1995) Suppression of the tumorigenic phenotype of a rat liver epithelial tumor cell by the p 11.2-p12 region of human chromosome 11. Mol. Carcinogenesis, 13, 220-232.
363. Coleman, W.B., Presnell, S.C., Borchert, K.M., Esch, G.L., McCullough, K.D., Weissman, B.E., Smith, G.J. and Grisham, J.W. (1996) Induction of rat WT-1 expression correlates with suppression of tumorigenicily in rat liver epithelial cell lines by human chromosome 11p11.2-p12. Cancer Res., submitted.
364. Okuda, K., Ohtsuki, T., Obata, H., Tomimatsu, M., Okazaki, N., Hasegawa, H., Nakajima, Y. and Onishi, K. (1985) Natural history of hepatocellular carcinoma and prognosis in relation to treatment study of 850 patients. Cancer, 56, 918-928.
365. Colombo, M., DeFranchis, R., DelNinno, E. et al. (1991) Hepatocellular carcinoma in Italian patients with cirrhosis. N. Engl. J. Med, 325, 675-680.
366. Oka, H., Kurioka, N., Kim, K., Kanno, T., Kuroki, T., Mizoguchi, Y. and Kobayashi, K. (1990) Prospective study of early detection of hepatocellular carcinoma in patients with cirrhosis. Hepatology, 12, 680-687.
367. Kato, Y., Nakata, K., Omagari, K. et al. (1994) Risk of hepatocellular carcinoma in patients with cirrhosis in Japan. Analysis of infectious hepatitis viruses. Cancer, 74, 2224-2228.
368. Shiratori, Y., Shiina, S., Imamura, M. et al. (1995) Characteristic differences of hepatocellular carcinoma between hepatitis B- and C-viral infection in Japan. Hepatology, 22, 1027-1033.
369. McMahon, B.J., Alberts, S.R., Wainwright, R.B., Bulkow, L. and Lanier, A.P (1990) Hepatitis B-related sequelae. Prospective study in 1400 hepatitis B surface-antigen positive Alaskan native carriers. Arch. Intern. Med., 150, 1051-1054.
370. McMahon, B.J., Alward, W.L.M., Hall, D.B., Heyward, W.L., Bender, T.R., Francis, D.P. and Maynard, J.E. (1985) Acute hepatitis B virus infection, relation of age to the clinical expression of disease and subsequent development of the carrier state. J. Infect. Dis., 151, 599-603.
371. Okuda, K. Nakashima, T., Kojiro, M., Kondo, Y. and Wada, K. (1989) Hepatocellular carcinoma without cirrhosis in Japanese patients. Gastroenterology, 97, 140-146.
372. Kew, M.C. (1989) Hepatocellular carcinoma with and without cirrhosis. A comparison in Southern African Blacks. Gastroenterology, 97, 136-139.
373. Kiyosawa, K., Sodeyama, T., Tanaka, E. et al. (1990) Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma, analysis by detection of hepatitis C virus. Hepatology, 12, 671-675.
374. Okazaki, N., Yoshino, M., Yoshida, T. et al. (1989) Evaluation of the prognosis for small hepatocellular carcinoma based on tumor volume doubling time. Cancer, 63, 2207-2210.
375. Klatskin, G. (1977) Hepatic tumors, possible relationship to use of oral contraceptives. Gastroenterology, 73, 386-394.
376. Palmer, J.R., Rosenberg, L., Kaufman, D.W., Warshauer, M.E., Stolley, P. and Shapiro, S. (1989) Oral contraceptive use and liver cancer. Am, J. Epidemiol., 130, 878-882.
377. Tavani, A., Negri, E., Parazzini, F., Franceschi, S. and LaVecchia, C. (1993) Female hormone utilization and the risk of hepatocellular cancer. Brit. J. Cancer, 67, 635-637.
378. Sweeney, E.C. and Evans, D.J. (1976) Hepatic lesions in patients treated with synthetic anabolic steroids. J. Clin. Pathol., 29, 626-633.
379. Boyd, P.R. and Mark, G.J. (1977) Multiple hepatic adenomas and a hepatocellular carcinoma in a man on oral methyl testosterone for eleven years. Cancer, 40, 1765-1770.
380. Hsing, A.W., Hoover, R.N., McLaughlin, J.K., Co-Chien, H.T., Wacholder, S., Blot, W.J. and Fraumen,F. (1992) Oral contraceptives and primary liver cancer among young women. Cancer Causes Cont., 3, 43-48.
381. Sass, B., Rabstein, L.S., Madison, R., Nims, R.M., Peters, R.L. and Kelloff, G.J. (1975) Incidence of spontaneous neoplasms in F344 rats throughout the natural life-span. J. Natl Cancer fast., 54, 1449-1456.
382. Goodman, D.G., Ward, J.M., Squire, R.A., Chu, K.C. and Linhart, M.S. (1979) Neoplastic and non-neoplastic lesions in aging F344 rats. Toxicol. Appl. Pharmacol., 48, 237-248.
383. Rice, J.M. (1969) Transplacental carcinogenesis in mice by 1-ethyl-l-nitrosourea. Ann. N.Y. Acad. Sci., 163, 813-826.
384. Vesselinovitch, S.D. and Mihailovich, N. (1983) Kinetics of diethylnitrosarnine hepatocarcinogenesis in the infant mouse. Cancer Res., 43, 4253-4259.
385. Fearon, E.R. and Vogelstein, B. (1990) A model for colorectal tumorigenesis. Cell, 61, 759-767.
386. Moertel, C.G. (1966) Multiple primary malignant neoplasms, introduction and presentation of the data. Recent Results Cancer Res., 7, 1-21.
387. Hajdu, S.I. and Hajdu, E.D. (1968) Multiple primary malignant tumors. J. Am. Geriat. Soc., 16, 16-26.
388. Nzeako, U.C., Goodman, Z.D. and Ishak, K.G. (1994) Association of hepatocellular carcinoma in North American patients with extrahepatic primary malignancies. Cancer, 74, 2765-2771.
389. Lynch, H.T. and Lynch, P.M. (1979) The cancer family syndrome, a pragmatic basis for syndrome identification. Dis. Colon Rectum, 22, 106-110.
390. Stein, W.D. (1991) Analysis of cancer incidence data on the basis of multistage and clonal growth models. Adv. Cancer Res., 56, 161-213.
391. DiPaolo, J.A. (1983) Relative difficulties in transforming human and animal cells in vitro. J. Natl Cancer Inst., 70, 3-8.
392. Harley, C.B. and Villeponteau, B. (1995) Telomeres and telomerase in aging and cancer. Current Opin. Genet. Dev., 5, 249-255.
393. Tahara, H., Nakanishi, T., Kitamoto, M., Nakashio, R., Shay, J.W., Tahara, E., Kajiyama, G. and Ide, T. (1995) Telomerase activity in human liver tissue, comparison between chronic liver disease and hepatocellular carcinomas. Cancer Res., 55, 2734-2736.
394. Onashi, K., Tsutsumi, M., Kobitsu, K. et al (1996) Shortened telomere length in hepatocellular carcinomas and corresponding background liver tissues in patients infected with hepatitis virus. Japan. J. Cancer Res., 87, 419-422.
395. Prowse, K.R. and Greider, C.W. (1995) Developmental and tissue-specific regulation of mouse telomerase and telomere length. Proc. Natl Acad. Sci. USA, 92, 4818-4822.
396. Chadeneau, C., Siegel, P., Harley, C.B., Muller, W.J. and Bacchetti, S. (1995) Telomerase activity in normal and malignant murine tissues. Oncogene, 11, 893-898.
397. Squire, J. and Weksberg, R. (1996) Genomic imprinting in tumours. Semin. Cancer Biol., 7, 41-47.
398. Davies, S.M. (1994) Developmental regulation of genomic imprinting of the IGF2 gene in human liver. Cancer Res., 54, 2560-2562.
399. Kalscheuer, V.M., Mariman, E.C., Schepens, M.T., Rehden, H. and Ropers, H.-H. (1993) The insulin-like growth factor gene is imprinted in the mouse but not in humans. Nature Genet., 5, 74-78.
400. Guengerich, F.P. (1992) Metabolic activation of carcinogens. Pharmac. Therap., 54, 17-61.
401. Lin, J.H. (1995) Species similarities and differences in pharmacokinetics. Drug Metab. Disp., 23, 1008-1021.
402. Eberhart, D.C., Gemczik, B., Halvorson, M.R. and Parkinson,A. (1991) Species differences in the toxicity and cytochrome IIIA-dependent metabolism of digitoxin. Mol. Pharmacol., 40, 859-867.
403. Pearce, R., Greenway, D. and Parkinson, A. (1992) Species differences and interindividual variation in liver microsomal cytochrome P450 2-A enzymes, effects on coumarin, dicumarol and testosterone oxidation. Arch. Biochem. Biophys., 296, 211-225.
404. Fernandez-Salguero, P. and Gonzalez, FJ. (1995) The CYP2A gene subfamily, species differences, regulation, catalytic activities and role in chemical carcinogenesis. Pharmacogenetics, 5, S123-S128.
405. Lin, D.-X., Lang, N.P. and Kadlubar, F.F. (1995) Species differences in the biotransformation of the food-borne carcinogen 2-amino-l-methyl-6-phenylimidazo(4,5-6)pyridine by hepatic microsomes and cytosols from humans, rats and mice. Drug Metab. Disp., 23, 518-524.
406. Olsen, J. and Overvad, K. (1993) The concept of multifactorial etiology of cancer Pharm. Toxicol., 72, S33-S38.
407. Guebel, A.P., Pauwels, S., Buchet, J.P., Dumont, E. and Dine, C. (1987) Increased CYT P-450 dependent function in healthy HBsAg carriers. Pharmaceut. Therap., 33, 193-196.
408. DeFlora, S., Hiltanen, E., Bartsch, H., Camourano, A., Izzotti, A., Bagnaoco, M. and Millman, I. (1989) Enhanced metabolic activation of chemical hepatocarcinogen in woodchucks infected with hepatitis B virus. Carcinogenesis, 10, 1099-1106.
409. Wild, C.P., Shrestha, S.M., Anwar, W.A. and Montesano,R. (1992) Field studies on aflatoxin exposure, metabolism and induction of genetic alterations in relation to HBV infection and hepatocellular carcinoma in The Gambia and Thailand. Toxicol Lett., 64/65, 455-461.
410. Kekule, A.S., Lauer, V., Weis, L., Luber, B. and Hofschneider, P.H. (1993) Hepatitis B virus transactivator HBx uses tumour promoter signalling pathway. Nature, 361, 742-745.
411. Takada, S., Kido, H., Fukutomi, A., Mori, T. and Koike, K. (1994) Interaction of hepatitis B virus X protein with a serine protease, tryptase TL2, as an inhibitor. Oncogene, 9, 341-348.
412. Wang, X.W., Forrester, K., Yeh, H., Feitelson, M.A., Gu, J.R. and Harris, C.C. (1994) Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity and association with transcription factor ERCC3. Proc. Natl Acad. Sci. USA, 91, 2230-2234.
413. Huff, J. (1993) Issues and controversies surrounding qualitative strategies for identifying and forecasting cancer causing agents in the human environment. Pharmac. Ther., 72, S12-S27.
414. Moen, C.J.A., Groot, P.C., Hart, A.A.M., Snoek, M. and Demant, P (1996) Fine mapping of colon tumor susceptibility (Sec) genes in the mouse, different from genes known to be somatically mutated in colon carcinoma. Proc. Natl Acad. Sci. USA, 93, 1082-1086.
415. Su, L.-K., Kinzler, K.W., Vogelstein, B., Preisinger, A.C., Mosev, A.R., Luongo, C., Gould, K.A. and Dove, W.F. (1992) Multiple intestinal neoplasia caused by mutation in the murine homolog of the APC gene. Science, 256, 322-324.
416. Oshima, M., Oshima, H., Kitigawa, K., Kobayashi, M., Itakura, C. and Taketo, M. (1995) Loss of Ape heterozygosity and abnormal tissue building in nascent intestinal polyps in mice carrying a truncated Ape gene. Proc. Natl Acad. Sci. USA, 92, 4482-4486.
417. Reitmair, A.H., Cai, J.-C, Bjerknes, M. et al (1996) MSH2 deficiency contributes to accelerated APC-mediated intestinal tumorigenesis. Cancer Res., 56, 2922-2926.
418. Nandi, S., Guzman, R.C., and Yang, J. (1995) Hormones and mammary carcinogenesis in mice, rats and humans, a unifying hypothesis, Proc. Natl Acad. Sci. USA, 92, 3650-3657.